Ultragenyx Pharmaceutical Inc (RARE)
41.50
+0.35
(+0.85%)
USD |
NASDAQ |
Jan 03, 16:00
41.55
+0.05
(+0.12%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Market Cap: 3.832B for Jan. 3, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Alnylam Pharmaceuticals Inc | 30.22B |
NovaBay Pharmaceuticals Inc | 3.017M |
Palatin Technologies Inc | 26.78M |
iBio Inc | 22.42M |
Theriva Biologics Inc | 4.424M |
Market Cap Related Metrics
PS Ratio | 6.898 |
Price to Book Value | 11.05 |
Price | 41.50 |
Earnings Yield | -15.59% |